GB1060786A
(en)
*
|
1963-10-09 |
1967-03-08 |
Wander Ag Dr A |
Process for the preparation of lactams
|
US3519647A
(en)
|
1966-10-12 |
1970-07-07 |
Squibb & Sons Inc |
2,3,4,5-tetrahydro-1,5-benzothiazepines
|
DE3561317D1
(en)
*
|
1984-01-27 |
1988-02-11 |
Ajinomoto Kk |
Manufacture of heptanoic acid derivatives
|
EP0238700B1
(en)
|
1986-03-27 |
1991-01-23 |
Topy Industries, Limited |
Carbon monoxide oxidizing catalyst
|
US4567254A
(en)
*
|
1984-09-19 |
1986-01-28 |
Kikkoman Corporation |
Method for preparing N6,8-disubstituted 3',5'-cyclic adenosine monophosphate and salt thereof
|
US4849535A
(en)
|
1985-02-26 |
1989-07-18 |
Ajinomoto Co., Inc. |
Production of cyclopentenylheptanoic acid derivatives
|
US4841055A
(en)
*
|
1985-03-25 |
1989-06-20 |
Japan Tobacco Inc. |
Desmosine derivatives and reagent for preparing artificial antigens
|
US4723012A
(en)
*
|
1985-03-25 |
1988-02-02 |
Japan Tobacco Inc. |
Desmosine derivatives having a disulfide bond and preparation of artificial antigen using the same
|
US6956032B1
(en)
*
|
1986-04-18 |
2005-10-18 |
Carnegie Mellon University |
Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
|
JPS63227599A
(ja)
|
1987-03-14 |
1988-09-21 |
Kirin Brewery Co Ltd |
アンスラサイクリン化合物およびその用途
|
US5210266A
(en)
*
|
1987-12-03 |
1993-05-11 |
Dainippon Pharmaceutical Co., Ltd. |
N-substituted mercaptopropanamide derivatives
|
US5179125A
(en)
*
|
1987-12-03 |
1993-01-12 |
Dainippon Pharmaceutical Co., Ltd. |
N-substituted mercaptopropanamide derivatives
|
DE58901634D1
(de)
*
|
1988-11-05 |
1992-07-16 |
Bayer Ag |
Verfahren zur kernchlorierung von aromatischen kohlenwasserstoffen.
|
US5272164A
(en)
|
1988-12-27 |
1993-12-21 |
Kirin Beer Kabushiki Kaisha |
Carboximidamide derivatives
|
JPH0662567B2
(ja)
|
1988-12-27 |
1994-08-17 |
麒麟麦酒株式会社 |
ピリジンカルボキシイミダミド誘導体、その製造中間体、製造法および用途
|
US5223508A
(en)
*
|
1988-12-27 |
1993-06-29 |
Kirin Beer Kabushiki Kaisha |
Pyridyl carboximidamide compounds useful in treating blood pressure
|
US5142647A
(en)
|
1989-04-18 |
1992-08-25 |
Japan Tobacco, Inc. |
Magnus measuring apparatus
|
CA1341094C
(en)
*
|
1989-09-25 |
2000-09-05 |
Ronald G. Worton |
Diagnosis for malignant hyperthermia
|
EP0446374B1
(en)
*
|
1989-09-30 |
1996-02-07 |
Kirin Beer Kabushiki Kaisha |
Method of producing seedling
|
US5153184A
(en)
|
1989-10-10 |
1992-10-06 |
Dowelanco |
((N-heterocyclyl)carbonyl)phosphoramidothioate ester insecticides
|
US5075293A
(en)
|
1989-10-10 |
1991-12-24 |
The Dow Chemical Company |
((N-heterocyclyl)carbonyl)phosphoramidothioate ester insecticides
|
KR940000166B1
(ko)
*
|
1989-11-09 |
1994-01-08 |
니혼다바고 상교오 가부시기가이샤 |
신규 글루코사민 유도체 및 이것을 막 구성성분으로서 함유한 리포솜
|
US4963671A
(en)
|
1989-11-20 |
1990-10-16 |
E. R. Squibb & Sons, Inc. |
Process for resolving chiral intermediates used in making calcium channel blockers
|
EP0460239A4
(en)
*
|
1989-12-27 |
1992-05-06 |
Japan Tobacco Inc. |
1,3,2-dioxathiolane oxide derivative
|
US5204462A
(en)
*
|
1990-03-30 |
1993-04-20 |
Japan Tobacco, Inc. |
4h-3,1-benzoxazin-4-one derivative
|
JP2651043B2
(ja)
*
|
1990-07-10 |
1997-09-10 |
麒麟麦酒株式会社 |
ジフェニルメチルピペラジン誘導体
|
US5082847A
(en)
|
1990-07-18 |
1992-01-21 |
Syntex (U.S.A.) Inc. |
Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility
|
US5064810A
(en)
|
1990-09-14 |
1991-11-12 |
Jeffrey Askanazi |
Use of branched chain amino acids to effect diaphragm contractility and fatigue
|
JP2703408B2
(ja)
|
1990-12-28 |
1998-01-26 |
麒麟麦酒株式会社 |
1,4‐ベンゾチアゼピン誘導体
|
DE4102103A1
(de)
*
|
1991-01-25 |
1992-08-20 |
Bayer Ag |
Substituierte benzoxazepine und benzthiazepine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
|
EP0533951A4
(en)
|
1991-04-10 |
1993-09-01 |
Japan Tobacco Inc. |
Novel oxazinone derivative
|
US5182272A
(en)
*
|
1991-05-03 |
1993-01-26 |
G. D. Searle & Co. |
8-substituted-dibenz[b,f][1,4]oxazepine-10(11)-carboxylic acid, substituted hydrazides, pharmaceutical compositions, and methods for treating pain
|
US5180720A
(en)
*
|
1991-05-03 |
1993-01-19 |
G. D. Searle & Co. |
2- and 3-alkoxy or hydroxy-8-substituted-dibenz[b,f]-[1,4]oxazepine-10(11H)-carboxylic acid, substituted hydrazides and methods for treating pain
|
ATE180830T1
(de)
|
1991-07-04 |
1999-06-15 |
Japan Tobacco Inc |
Verfahren zur kultivierung von vorläufer t- zellinien
|
US5593988A
(en)
*
|
1991-10-11 |
1997-01-14 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Therapeutic agent for osteoporosis and diazepine compound
|
AU3143593A
(en)
*
|
1991-12-20 |
1993-07-28 |
G.D. Searle & Co. |
Substituted dibenzoxazepines or dibenzothiazepines and their use as prostaglandin E2 antagonists
|
MX9300433A
(es)
*
|
1992-01-28 |
1994-07-29 |
Kirin Brewery |
Compuestos de piridincarboximidamina y composiciones farmaceuticas que los contienen.
|
GB9203347D0
(en)
*
|
1992-02-17 |
1992-04-01 |
Wellcome Found |
Hypolipidaemic compounds
|
JP2667351B2
(ja)
|
1992-03-24 |
1997-10-27 |
麒麟麦酒株式会社 |
食餌脂質消化吸収阻害剤および飲食品
|
US5387684A
(en)
*
|
1992-03-25 |
1995-02-07 |
The Green Cross Corporation |
Isoindazole compound
|
JP3093419B2
(ja)
|
1992-03-30 |
2000-10-03 |
麒麟麦酒株式会社 |
1,4‐ベンゾチアゼピン誘導体
|
US5304644A
(en)
*
|
1992-04-15 |
1994-04-19 |
G. D. Searle & Co. |
1-,2-,3-,4-,5-,6-,7-,8- and/or 9 substituted dibenzoxazepine compounds, pharmaceutical compositions and methods for treating pain
|
US5478832A
(en)
|
1992-05-08 |
1995-12-26 |
The Green Cross Corporation |
Quinoline compounds
|
RU94046317A
(ru)
|
1992-07-02 |
1996-10-20 |
Фудзисава Фармасьютикал Ко. |
Новое синтетическое промежуточное соединение для получения производных и способы получения производных аминокислот
|
WO1994004523A1
(en)
*
|
1992-08-21 |
1994-03-03 |
Japan Tobacco Inc. |
Dioxacycloalkane compound with renin-inhibiting activity
|
US5260286A
(en)
|
1992-10-16 |
1993-11-09 |
Japan Tobacco, Inc. |
2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
|
NZ257843A
(en)
|
1992-11-09 |
1996-10-28 |
Boots Co Plc |
2,3,4,5-tetrahydro-1,4-benzothiazepine derivatives optionally substituted in position-6 by methyl, fluoro or chloro
|
US5354758A
(en)
|
1992-12-16 |
1994-10-11 |
Japan Tobacco Inc. |
Benzomorphans useful as NMDA receptor antagonists
|
ZA94284B
(en)
*
|
1993-01-27 |
1994-08-17 |
Shionogi & Co |
Process for preparing benzothiazepine derivatives
|
ZA941003B
(en)
*
|
1993-02-15 |
1995-08-14 |
Wellcome Found |
Hypolipidaemic compounds
|
IL108634A0
(en)
|
1993-02-15 |
1994-05-30 |
Wellcome Found |
Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them
|
JP4020958B2
(ja)
|
1993-04-15 |
2007-12-12 |
キリンファーマ株式会社 |
新規スフィンゴ糖脂質およびその使用
|
US5461047A
(en)
|
1993-06-16 |
1995-10-24 |
G. D. Searle & Co. |
2-,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use
|
US5354747A
(en)
|
1993-06-16 |
1994-10-11 |
G. D. Searle & Co. |
2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use
|
JP3437577B2
(ja)
|
1993-08-19 |
2003-08-18 |
日本たばこ産業株式会社 |
植物由来のatp依存フルクトース6リン酸1ホスホトランスフェラーゼをコードするdna,それを含む組換えベクター及びそれを用いる低温下で植物細胞中の糖含量を変化させる方法
|
FR2709753B1
(fr)
|
1993-09-09 |
1995-12-01 |
Hoechst Lab |
Nitrates organiques, leur procédé de préparation et leur application comme médicaments.
|
US6897295B1
(en)
*
|
1993-11-10 |
2005-05-24 |
Mochida Pharmaceutical Co., Ltd. |
Antibodies and fragments thereof to Fas ligand and Fas ligand derived polypeptides
|
US5719155A
(en)
*
|
1993-11-10 |
1998-02-17 |
Japan Tobacco Inc. |
Chroman derivative and pharmaceutical use thereof
|
JPH08127594A
(ja)
*
|
1993-11-10 |
1996-05-21 |
Mochida Pharmaceut Co Ltd |
Fas抗原に結合する新規蛋白質およびそれをコードするDNA
|
JP3914272B2
(ja)
|
1993-12-28 |
2007-05-16 |
中外製薬株式会社 |
アドゼベリンをコードする遺伝子
|
JP2706755B2
(ja)
*
|
1994-02-10 |
1998-01-28 |
日本たばこ産業株式会社 |
新規なベンジルアミノエトキシベンゼン誘導体
|
US5457182A
(en)
|
1994-02-15 |
1995-10-10 |
Merck & Co., Inc. |
FK-506 cytosolic binding protein, FKBP12.6
|
US5449675A
(en)
|
1994-06-09 |
1995-09-12 |
G. D. Searle & Co. |
Substituted dibenzoxazepine and dibenzthiazepine urea compounds, pharmaceutical compositions and methods of use
|
US20040175814A1
(en)
|
1994-06-15 |
2004-09-09 |
Kirin Beer Kubushiki Kaisha |
Novel transferase and amylase, process for producing the enzymes, use thereof, and gene coding for the same
|
DE69534685T2
(de)
*
|
1994-06-15 |
2006-09-07 |
Kirin Beer K.K. |
Transferase und amylase, verfahren zur herstellung dieser enzyme, ihre verwendung und für die kodierende gene
|
ZA956647B
(en)
|
1994-08-10 |
1997-02-10 |
Wellcome Found |
Hypolipidaemic compounds.
|
WO1996015152A1
(fr)
|
1994-11-11 |
1996-05-23 |
International Reagents Corporation |
Anticorps monoclonal antiannexine-v, procede pour produire cet anticorps, et utilisation de cet anticorps
|
CA2205173A1
(en)
|
1994-11-18 |
1996-05-30 |
Takeshi Nakamura |
Therapeutic agent for osteoporosis and triazepine compound
|
US6632976B1
(en)
*
|
1995-08-29 |
2003-10-14 |
Kirin Beer Kabushiki Kaisha |
Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene
|
US6660837B1
(en)
|
1995-09-14 |
2003-12-09 |
Kirin Beer Kabushiki Kaisha |
Modified protein derived from protein kinase N
|
JP3193301B2
(ja)
*
|
1995-09-14 |
2001-07-30 |
麒麟麦酒株式会社 |
生理活性タンパク質p160
|
US5906819A
(en)
*
|
1995-11-20 |
1999-05-25 |
Kirin Beer Kabushiki Kaisha |
Rho target protein Rho-kinase
|
US5866341A
(en)
*
|
1996-04-03 |
1999-02-02 |
Chugai Pharmaceutical Co., Ltd. |
Compositions and methods for screening drug libraries
|
ES2364179T3
(es)
|
1996-07-08 |
2011-08-26 |
Kyowa Hakko Kirin Co., Ltd. |
Compuestos con actividad receptora de calcio.
|
JP3861187B2
(ja)
*
|
1996-08-02 |
2006-12-20 |
住友精化株式会社 |
チアゼピン誘導体の製造方法
|
US6111072A
(en)
|
1996-08-26 |
2000-08-29 |
Kirin Beer Kabushiki Kaisha |
Rho target protein human mDia and gene encoding same
|
WO1998026053A1
(en)
*
|
1996-12-12 |
1998-06-18 |
Kirin Beer Kabushiki Kaisha |
NOVEL β1→4 N-ACETYLGLUCOSAMINYLTRANSFERASE AND GENE ENCODING THE SAME
|
TW555562B
(en)
*
|
1996-12-27 |
2003-10-01 |
Kirin Brewery |
Method for activation of human antigen-presenting cells, activated human antigen-presenting cells and use thereof
|
JP2894445B2
(ja)
*
|
1997-02-12 |
1999-05-24 |
日本たばこ産業株式会社 |
Cetp活性阻害剤として有効な化合物
|
JP3521382B2
(ja)
|
1997-02-27 |
2004-04-19 |
日本たばこ産業株式会社 |
細胞間接着及びシグナル伝達を媒介する細胞表面分子
|
US7112655B1
(en)
|
1997-02-27 |
2006-09-26 |
Japan Tobacco, Inc. |
JTT-1 protein and methods of inhibiting lymphocyte activation
|
JP3885177B2
(ja)
|
1997-03-26 |
2007-02-21 |
大塚製薬株式会社 |
ヒト遺伝子
|
US6313113B1
(en)
|
1997-04-15 |
2001-11-06 |
Reddy-Cheminor, Inc. |
Heterocyclic compounds having antidiabetic, hypolipidemic and antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
|
DE19722317C1
(de)
|
1997-05-28 |
1998-10-08 |
Boehringer Ingelheim Int |
Das Protein des humanen Ryanodinrezeptors vom Typ 3 sowie dafür kodierende DNA-Moleküle
|
AUPO941497A0
(en)
|
1997-09-24 |
1997-10-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Novel compounds
|
CA2274776C
(en)
|
1997-10-08 |
2008-11-25 |
Noboru Kaneko |
Method for analyzing annexin v in urine and use thereof
|
GB9724813D0
(en)
|
1997-11-25 |
1998-01-21 |
Univ Nottingham |
Reducing muscle fatigue
|
JP2959765B2
(ja)
*
|
1997-12-12 |
1999-10-06 |
日本たばこ産業株式会社 |
3−ピペリジル−4−オキソキナゾリン誘導体及びそれを含有してなる医薬組成物
|
EP1043335A4
(en)
*
|
1997-12-25 |
2005-08-31 |
Japan Tobacco Inc |
MONOCLONAL ANTIBODY AGAINST THE BIND WEIGHT GROWTH FACTOR AND ITS MEDICAL USES
|
US6583157B2
(en)
|
1998-01-29 |
2003-06-24 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
US6051714A
(en)
|
1998-03-12 |
2000-04-18 |
Reilly Industries, Inc. |
Processes for dechlorinating pyridines
|
AU754716B2
(en)
*
|
1998-03-26 |
2002-11-21 |
Japan Tobacco Inc. |
Amide derivatives and nociceptin antagonists
|
TR200002904T2
(tr)
*
|
1998-04-10 |
2001-02-21 |
Japan Tobacco Inc. |
Amidin bileşikleri
|
WO1999063984A1
(en)
*
|
1998-06-08 |
1999-12-16 |
Advanced Medicine, Inc. |
Novel sodium channel drugs and uses
|
US6890531B1
(en)
*
|
1998-07-31 |
2005-05-10 |
Kirin Beer Kabushiki Kaisha |
Neuronal growth factor galectin-1
|
AU5651799A
(en)
|
1998-09-17 |
2000-04-10 |
Nippon Kayaku Kabushiki Kaisha |
Remedies for photochemotherapy
|
US6506745B1
(en)
*
|
1998-12-28 |
2003-01-14 |
Noboru Kaneko |
Medicinal compositions for treatment of atrial fibrillation
|
WO2000058499A1
(fr)
*
|
1999-03-30 |
2000-10-05 |
Japan Tobacco Inc. |
Procede pour la production d'anticorps monoclonal
|
KR100686617B1
(ko)
|
1999-05-19 |
2007-02-23 |
가네꼬 노보루 |
1,4-벤조티아제핀유도체의 항암제 내성극복의약조성물
|
GB9914745D0
(en)
*
|
1999-06-24 |
1999-08-25 |
Knoll Ag |
Therapeutic agents
|
JP3871503B2
(ja)
|
1999-08-30 |
2007-01-24 |
日本たばこ産業株式会社 |
免疫性疾患治療剤
|
AU7097400A
(en)
*
|
1999-09-01 |
2001-03-26 |
Otsuka Pharmaceutical Co., Ltd. |
Platelet membrane glycoprotein vi (gpvi) dna and protein sequences, and uses thereof
|
DE60032620T2
(de)
*
|
1999-09-30 |
2007-10-04 |
Kaneko, Noboru |
Antikrebsmittel
|
TWI281915B
(en)
|
1999-12-24 |
2007-06-01 |
Kirin Brewery |
Quinoline and quinazoline derivatives and drugs containing the same
|
AU2733301A
(en)
*
|
1999-12-29 |
2001-07-09 |
Glaxo Group Limited |
Methods and compositions related to modulators of annexin and cartilage homeostasis
|
WO2001051923A2
(en)
|
2000-01-14 |
2001-07-19 |
Mitokor |
Screening assays using intramitochondrial calcium
|
US6906072B1
(en)
*
|
2000-01-20 |
2005-06-14 |
Eisai Co., Ltd. |
Piperazine compound and pharmaceutical composition containing the compound
|
AU2001228810A1
(en)
*
|
2000-01-26 |
2001-08-07 |
Ono Pharmaceutical Co. Ltd. |
Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
|
US6824973B2
(en)
|
2000-02-03 |
2004-11-30 |
Kirin Beer Kabushiki Kaisha |
Method of promoting stem cell proliferation or survival by contacting a cell with a stem cell factor-like polypeptide
|
ATE420878T1
(de)
|
2000-02-18 |
2009-01-15 |
Kyowa Hakko Kirin Co Ltd |
Isoxazol- und thiazolverbindungen und ihre verwendung als medikamente
|
CA2402436C
(en)
|
2000-03-24 |
2010-02-16 |
Pharmacia Corporation |
Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
|
US6787668B2
(en)
|
2000-04-13 |
2004-09-07 |
Pharmacia Corporation |
2-amino-4,5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
|
AR032318A1
(es)
|
2000-04-13 |
2003-11-05 |
Pharmacia Corp |
Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa
|
AR034120A1
(es)
|
2000-04-13 |
2004-02-04 |
Pharmacia Corp |
Compuesto derivado halogenado del acido 2-amino-4,5 heptenoico, composicion farmaceutica que lo comprende y el uso de dicho compuesto y dicha composicion en la fabricacion de un medicamento para inhibir o modular la sintesis de acido nitrico
|
US6545170B2
(en)
*
|
2000-04-13 |
2003-04-08 |
Pharmacia Corporation |
2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
|
US6489125B1
(en)
|
2000-05-10 |
2002-12-03 |
The Trustees Of Columbia University In The City Of New York |
Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
|
US20060293266A1
(en)
|
2000-05-10 |
2006-12-28 |
The Trustees Of Columbia |
Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
|
US20040048780A1
(en)
*
|
2000-05-10 |
2004-03-11 |
The Trustees Of Columbia University In The City Of New York |
Method for treating and preventing cardiac arrhythmia
|
US8022058B2
(en)
|
2000-05-10 |
2011-09-20 |
The Trustees Of Columbia University In The City Of New York |
Agents for preventing and treating disorders involving modulation of the RyR receptors
|
US7879840B2
(en)
|
2005-08-25 |
2011-02-01 |
The Trustees Of Columbia University In The City Of New York |
Agents for preventing and treating disorders involving modulation of the RyR receptors
|
US7718644B2
(en)
*
|
2004-01-22 |
2010-05-18 |
The Trustees Of Columbia University In The City Of New York |
Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
|
US20040229781A1
(en)
|
2000-05-10 |
2004-11-18 |
Marks Andrew Robert |
Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
|
US7393652B2
(en)
|
2000-05-10 |
2008-07-01 |
The Trustees Of Columbia University In The City Of New York |
Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
|
AU2001261434A1
(en)
|
2000-05-11 |
2001-11-26 |
Pharmacia Corporation |
Aldosterone antagonist composition for release during aldosterone acrophase
|
US20030220312A1
(en)
|
2000-05-11 |
2003-11-27 |
G.D. Searle & Co. |
Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of cardiovascular disorders
|
RU2262511C2
(ru)
|
2000-05-18 |
2005-10-20 |
Джапан Тобакко, Инк. |
Человеческое моноклональное антитело против ailim, костимулирующей молекулы передачи сигнала, и его фармацевтическое применение
|
JP3597140B2
(ja)
|
2000-05-18 |
2004-12-02 |
日本たばこ産業株式会社 |
副刺激伝達分子ailimに対するヒトモノクローナル抗体及びその医薬用途
|
AU2001267879A1
(en)
|
2000-07-05 |
2002-01-14 |
Ajinomoto Co., Inc. |
Acylsulfonamide derivatives
|
WO2002002101A1
(fr)
|
2000-07-05 |
2002-01-10 |
Ajinomoto Co., Inc. |
Composes hypoglycemiques
|
AU2001278045B2
(en)
*
|
2000-07-27 |
2006-08-03 |
Pharmacia Corporation |
Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
|
NZ523770A
(en)
|
2000-08-01 |
2004-11-26 |
Pharmacia Corp |
Hexahydro-7-1H-azepin-2-YL-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase
|
MY131964A
(en)
*
|
2000-09-15 |
2007-09-28 |
Pharmacia Corp |
2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
|
AR031608A1
(es)
|
2000-09-15 |
2003-09-24 |
Pharmacia Corp |
Derivados de los acidos 2-amino-2-alquil-3-hexenoico y -hexinoico utiles como inhibidores de oxido nitrico sintetasa
|
AR031129A1
(es)
|
2000-09-15 |
2003-09-10 |
Pharmacia Corp |
Derivados de los acidos 2-amino-2-alquil-4-hexenoico y -hexinoico utiles como inhibidores de oxido nitrico sintetasa
|
US6936426B2
(en)
*
|
2000-10-06 |
2005-08-30 |
Harbor-Ucla Research And Education Institute |
Detection of antibody mediated inflammatory auto-immune disorders
|
CA2430013C
(en)
*
|
2000-11-30 |
2011-11-22 |
Medarex, Inc. |
Transgenic transchromosomal rodents for making human antibodies
|
US6673904B2
(en)
*
|
2000-12-23 |
2004-01-06 |
Kirin Beer Kabushiki Kaisha |
Stem cell growth factor-like polypeptides
|
US6962926B2
(en)
|
2001-01-31 |
2005-11-08 |
Telik, Inc. |
Antagonist of MCP-1 function, and compositions and methods of use thereof
|
WO2002061076A1
(en)
*
|
2001-02-01 |
2002-08-08 |
Mochida Pharmaceutical Co., Ltd. |
Adiponectin-associated protein
|
JP4817514B2
(ja)
|
2001-03-09 |
2011-11-16 |
協和発酵キリン株式会社 |
新規動物細胞用ベクターおよびその使用
|
CA2440374A1
(en)
|
2001-03-14 |
2002-09-19 |
Takayuki Maruyama |
A pharmaceutical composition for the treatment of depression comprising the ep1 antagonist as active ingredient
|
US20030054531A1
(en)
*
|
2001-03-19 |
2003-03-20 |
Decode Genetics Ehf, |
Human stroke gene
|
WO2002078625A2
(en)
|
2001-03-28 |
2002-10-10 |
Pharmacia Corporation |
Therapeutic combinations for cardiovascular and inflammatory indications
|
NZ529046A
(en)
*
|
2001-04-27 |
2005-10-28 |
Kirin Brewery |
Quinoline derivative having azolyl group and quinazoline derivative
|
JP4230681B2
(ja)
|
2001-07-06 |
2009-02-25 |
株式会社東芝 |
高耐圧半導体装置
|
US20030220310A1
(en)
|
2001-07-27 |
2003-11-27 |
Schuh Joseph R. |
Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
|
GB0121621D0
(en)
*
|
2001-09-07 |
2001-10-31 |
Astrazeneca Ab |
Chemical compounds
|
JP4269052B2
(ja)
*
|
2001-09-14 |
2009-05-27 |
アムジエン・インコーポレーテツド |
連結ビアリール化合物
|
JP2003095977A
(ja)
*
|
2001-09-21 |
2003-04-03 |
Masafumi Yano |
筋肉収縮・弛緩機能障害関連疾患の治療又は予防剤
|
EP1452093A4
(en)
|
2001-11-15 |
2007-08-15 |
Kirin Brewery |
CHIMESE NON-MENTAL ANIMAL
|
JP2003145746A
(ja)
*
|
2001-11-16 |
2003-05-21 |
Seiko Epson Corp |
インクジェット記録方法及びインクジェット記録装置
|
AU2002354056A1
(en)
|
2001-11-19 |
2003-06-10 |
Ono Pharmaceutical Co., Ltd. |
Remedies for urinary frequency
|
US7163952B2
(en)
*
|
2001-12-03 |
2007-01-16 |
Japan Tobacco Inc. |
Azole compound and medicinal use thereof
|
WO2003061699A1
(fr)
|
2001-12-27 |
2003-07-31 |
Japan Tobacco, Inc. |
Remedes pour affections allergiques
|
US20040171613A1
(en)
|
2001-12-27 |
2004-09-02 |
Japan Tobacco Inc. |
Therapeutic agent for non-immediate type allergic diseases
|
JP2005521653A
(ja)
*
|
2002-01-17 |
2005-07-21 |
ファルマシア コーポレイション |
先端ナトリウム同時依存性胆汁酸輸送(asbt)およびタウロコール酸塩取込みの阻害剤としての新規アルキル/アリールヒドロキシまたはケトチエピン化合物
|
CN100543022C
(zh)
|
2002-02-01 |
2009-09-23 |
大日本住友制药株式会社 |
2-呋喃甲酸酰肼化合物及含该化合物的药物组合物
|
US20060233902A1
(en)
|
2002-02-14 |
2006-10-19 |
Kirin Beer Kabushiki Kaisha |
Compositions and foods for improving lipid metabolism
|
WO2003090570A1
(fr)
*
|
2002-04-26 |
2003-11-06 |
Japan Tobacco Inc. |
Dispositif de fabrication d'articles en forme de barre
|
US7439332B2
(en)
|
2002-04-26 |
2008-10-21 |
Kirin Pharma Kabushiki Kaisha |
Polypeptide having an activity to support proliferation or survival of hematopoietic stem or progenitor cells
|
JP4113042B2
(ja)
*
|
2002-05-24 |
2008-07-02 |
シチズンホールディングス株式会社 |
表示装置およびカラー表示方法
|
DE10237723A1
(de)
|
2002-08-17 |
2004-07-08 |
Aventis Pharma Deutschland Gmbh |
Verwendung von IKappaB-Kinase Inhibitoren in der Schmerztherapie
|
CZ2004627A3
(cs)
*
|
2002-08-30 |
2004-10-13 |
Japanátobaccoáinc |
Dibenzylaminové sloučeniny a jejich farmaceutické použití
|
JP2004103256A
(ja)
|
2002-09-04 |
2004-04-02 |
Nippon Chemicon Corp |
非常灯
|
JPWO2004024717A1
(ja)
|
2002-09-12 |
2006-01-05 |
麒麟麦酒株式会社 |
キナーゼ阻害活性を有するイソキノリン誘導体およびそれを含む医薬
|
EP1541153A1
(en)
|
2002-09-20 |
2005-06-15 |
Kirin Beer Kabushiki Kaisha |
Hepatitis c virus inhibitor comprising alpha-glycosylceramide as the active ingredient
|
EP1559782B1
(en)
|
2002-10-04 |
2016-12-21 |
Kyowa Hakko Kirin Co., Ltd. |
Human artificial chromosome (hac) vector
|
US7544678B2
(en)
|
2002-11-05 |
2009-06-09 |
The Trustees Of Columbia University In The City Of New York |
Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
|
WO2004042389A2
(en)
|
2002-11-08 |
2004-05-21 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d)
|
AU2003293006A1
(en)
|
2002-11-22 |
2004-06-18 |
Japan Tobacco Inc. |
Fused bicyclic nitrogen-containing heterocycles
|
EP1439221B1
(en)
|
2002-12-17 |
2007-01-24 |
F. Hoffmann-La Roche Ag |
PDE core construct
|
MXPA05008619A
(es)
|
2003-02-13 |
2005-11-04 |
Banyu Pharma Co Ltd |
Derivados novedosos de 2-piridincarboxamida.
|
WO2004080283A2
(en)
|
2003-03-07 |
2004-09-23 |
The Trustees Of Columbia University, In The City Of New York |
Type 1 ryanodine receptor-based methods
|
TWI220798B
(en)
|
2003-03-07 |
2004-09-01 |
Hitachi Cable |
Light-emitting diode array
|
ES2377121T3
(es)
|
2003-03-17 |
2012-03-22 |
Japan Tobacco Inc. |
Composiciones farmacéuticas de inhibidores de CETP
|
AU2004222436A1
(en)
|
2003-03-17 |
2004-09-30 |
Japan Tobacco Inc. |
Method for increasing the oral bioavailability of S-(2-(((1- (2-ethylbutyl) cyclohexyl)carbonyl) amino) phenyl)-2-methylpropanethioate
|
US20040235162A1
(en)
|
2003-03-18 |
2004-11-25 |
Kirin Beer Kabushiki Kaisha |
Method of preparing immunoregulatory dendritic cells and the use thereof
|
US20050032210A1
(en)
*
|
2003-03-18 |
2005-02-10 |
Kirin Beer Kabushiki Kaisha |
Method of preparing immuno-regulatory dendritic cells and the use thereof
|
CL2004000544A1
(es)
|
2003-03-18 |
2005-01-28 |
Pharmacia Corp Sa Organizada B |
Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopati
|
JP4926473B2
(ja)
|
2003-03-27 |
2012-05-09 |
協和発酵キリン株式会社 |
生体内リン輸送を阻害する化合物およびそれを含んでなる医薬
|
BRPI0409136A
(pt)
|
2003-04-09 |
2006-04-25 |
Japan Tobacco Inc |
composto heteroaromático pentacìclico e uso medicinal do mesmo
|
US20060135506A1
(en)
|
2003-04-22 |
2006-06-22 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
|
US20050009733A1
(en)
*
|
2003-04-22 |
2005-01-13 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of central nervous system damage
|
US20040229803A1
(en)
|
2003-04-22 |
2004-11-18 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of pain, inflammation or inflammation mediated disorders
|
US20050159403A1
(en)
|
2003-04-22 |
2005-07-21 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of central nervous system damage
|
TWI494102B
(zh)
*
|
2003-05-02 |
2015-08-01 |
Japan Tobacco Inc |
包含s-〔2(〔〔1-(2-乙基丁基)環己基〕羰基〕胺基)苯基〕2-甲基丙烷硫酯及hmg輔酶a還原酶抑制劑之組合
|
US20050070543A1
(en)
*
|
2003-07-11 |
2005-03-31 |
Pharmacia Corporation |
Compositions of a chromene or phenyl acetic acid cyclooxygenase-2 selective inhibitor and an ACE inhibitor for the treatment of central nervous system damage
|
WO2005013907A2
(en)
*
|
2003-08-07 |
2005-02-17 |
Japan Tobacco Inc. |
Pyrrolo[1,2-b]pyridazine derivatives
|
US20070010571A1
(en)
*
|
2003-08-20 |
2007-01-11 |
Nitromed, Inc. |
Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
|
CA2536975A1
(en)
*
|
2003-08-28 |
2005-03-17 |
Nitromed, Inc. |
Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
|
US20050187221A1
(en)
|
2003-09-08 |
2005-08-25 |
Japan Tobacco Inc. |
Method of treating ischemia reperfusion injury
|
WO2005063247A1
(en)
|
2003-12-22 |
2005-07-14 |
Amgen Inc. |
Aryl sulfonamide compounds and uses related thereto
|
US7165879B2
(en)
|
2004-03-25 |
2007-01-23 |
Red Devil Equipment Company |
Clamp lock apparatus and method for a paint mixer
|
JP2007533328A
(ja)
*
|
2004-04-22 |
2007-11-22 |
キリンホールディングス株式会社 |
トランスジェニック動物及びその用途
|
AU2005238389B2
(en)
|
2004-04-28 |
2009-08-06 |
Aetas Pharma Co., Ltd. |
Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure
|
US7378423B2
(en)
*
|
2004-06-11 |
2008-05-27 |
Japan Tobacco Inc. |
Pyrimidine compound and medical use thereof
|
JP3968358B2
(ja)
*
|
2004-06-30 |
2007-08-29 |
日本電信電話株式会社 |
薄型フラットツイストぺアすきまケーブル及びすきまナビゲータユニット
|
NZ552086A
(en)
*
|
2004-07-15 |
2009-12-24 |
Japan Tobacco Inc |
Fused benzamide compound and vanilloid receptor 1 (VR1) activity inhibitor
|
JP2006094849A
(ja)
|
2004-08-30 |
2006-04-13 |
Kirin Brewery Co Ltd |
相同組換え効率が向上した分化多能性細胞及びその利用
|
AR051780A1
(es)
*
|
2004-11-29 |
2007-02-07 |
Japan Tobacco Inc |
Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
|
JP2008531579A
(ja)
|
2005-02-24 |
2008-08-14 |
ニトロメッド インコーポレーティッド |
酸化窒素増強利尿化合物、組成物および使用方法
|
WO2006093247A1
(ja)
|
2005-02-28 |
2006-09-08 |
Japan Tobacco Inc. |
Syk阻害活性を有する新規なアミノピリジン化合物
|
WO2006098394A1
(ja)
|
2005-03-14 |
2006-09-21 |
Japan Tobacco Inc. |
脂質吸収抑制方法および脂質吸収抑制剤
|
US7704990B2
(en)
|
2005-08-25 |
2010-04-27 |
The Trustees Of Columbia University In The City Of New York |
Agents for preventing and treating disorders involving modulation of the RyR receptors
|